Blocking Fas signaling in adipose tissue ameliorates obesity-associated inflammation, insulin resistance, and hepatosteatosis
Journal of Pharmaceutical Investigation · 2024-07 · 54 (4) · 519-537
DOI: 10.1007/s40005-024-00668-9 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Pharmaceutical Investigation, online erschienen am 22.02.2024. Verfasst von Jagadish Beloor und 10 weiteren Autor:innen. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 53 Literaturangaben. Gefördert von: Korea Research Foundation.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Förderung
- Korea Research Foundation
Zitieren
APA
Beloor, J., Ullah, I., Kim, J., Choi, C., Kim, S., Chung, K., KR, J., Yi, Y., Rhim, T., Kumar, P., & Lee, S. (2024). Blocking Fas signaling in adipose tissue ameliorates obesity-associated inflammation, insulin resistance, and hepatosteatosis. Journal of Pharmaceutical Investigation, 54(4), 519-537. https://doi.org/10.1007/s40005-024-00668-9
Vancouver
Beloor J, Ullah I, Kim J, Choi C, Kim S, Chung K, et al. Blocking Fas signaling in adipose tissue ameliorates obesity-associated inflammation, insulin resistance, and hepatosteatosis. Journal of Pharmaceutical Investigation. 2024;54(4):519-537. doi:10.1007/s40005-024-00668-9
BibTeX
@article{Beloor2024,
author = {Beloor, Jagadish and Ullah, Irfan and Kim, Jongkil and Choi, Changseon and Kim, Sunghwa and Chung, Kunho and KR, Jyothi and Yi, Yujong and Rhim, Taiyoun and Kumar, Priti and Lee, Sang-Kyung},
title = {Blocking Fas signaling in adipose tissue ameliorates obesity-associated inflammation, insulin resistance, and hepatosteatosis},
journal = {Journal of Pharmaceutical Investigation},
year = {2024},
volume = {54},
number = {4},
pages = {519--537},
doi = {10.1007/s40005-024-00668-9}
}
EUVIMED